Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with <scp>NICE</scp> guidelines and <scp>ACOG</scp> recommendationsN. O’Gorman, K. H. Nicolaides, N. Karagiotis et al.|Ultrasound in Obstetrics and Gynecology|2017Cited by 363
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsiaD. Wright, K. H. Nicolaides, Liona C. Poon et al.|American Journal of Obstetrics and Gynecology|2017Cited by 166
Prediction of pre‐eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from <scp>EVENTS</scp> trialZ. Benkő, K. H. Nicolaides, Alan Wright et al.|Ultrasound in Obstetrics and Gynecology|2020Cited by 46
<scp>STATIN</scp> trial: predictive performance of competing‐risks model in screening for pre‐eclampsia at 35–37 weeks' gestationMoritz Döbert, K. H. Nicolaides, Alan Wright et al.|Ultrasound in Obstetrics and Gynecology|2021Cited by 31
OC07.02: Multicentre screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison to NICE guidelines and ACOG recommendationsN. O’Gorman, K. H. Nicolaides, D. Wright et al.|Ultrasound in Obstetrics and Gynecology|2017Cited by 1